H Rübsamen-Waigmann Selected Research

GW420867

7/2000

Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Rübsamen-Waigmann Research Topics

Disease

5	Infections 12/2002 - 06/2000
2	Warts (Wart) 12/2002 - 04/2001
1	Vesicular Stomatitis 07/2006
1	Fibroma (Fibromatosis) 12/2002
1	Papilloma (Papillomatosis) 12/2002
1	Virus Diseases (Viral Diseases) 07/2001
1	Papillomavirus Infections 04/2001
1	Coinfection 03/2001
1	Viremia 07/2000
1	HIV Infections (HIV Infection) 06/2000

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 12/2002 - 03/2001
2	Viral DNAIBA 12/2002 - 04/2001
2	Antiviral Agents (Antivirals)IBA 04/2001 - 07/2000
2	AntigensIBA 04/2001 - 03/2001
1	IntegrasesIBA 07/2006
1	LigandsIBA 07/2001
1	Virus ReceptorsIBA 07/2001
1	Complex MixturesIBA 04/2001
1	RNA (Ribonucleic Acid)IBA 03/2001
1	GW420867IBA 07/2000
1	Reverse Transcriptase InhibitorsIBA 07/2000
1	Pharmaceutical PreparationsIBA 07/2000
1	Neutralizing AntibodiesIBA 06/2000
1	EpitopesIBA 06/2000
1	AntibodiesIBA 06/2000
1	Immunoglobulin G (IgG)IBA 06/2000

Therapy/Procedure

1	Heterologous Transplantation (Xenotransplantation) 04/2001
1	Therapeutics 07/2000